Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.
暂无分享,去创建一个
A. Plückthun | P. Pack | A Plückthun | P Pack | A. Plückthun | P. Pack
[1] G. Jung,et al. An in-vitro model for tumor immunotherapy with antibody heteroconjugates. , 1988, Immunology today.
[2] P. V. von Hippel,et al. Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.
[3] S. Kaufmann,et al. Progress in Immunology , 1989, Springer Berlin Heidelberg.
[4] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[5] P. S. Kim,et al. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. , 1991, Science.
[6] A. Plückthun,et al. The Functional Expression of Antibody Fv Fragments in Ischhuchia coli: Improved Vectors and a Generally Applicable Purification Technique , 1991, Bio/Technology.
[7] J. Vieira,et al. Production of single-stranded plasmid DNA. , 1987, Methods in enzymology.
[8] L. Hood,et al. The generation of diversity in phosphorylcholine-binding antibodies. , 1984, Advances in immunology.
[9] M. Potter. ANTIGEN‐BINDING MYELOMA PROTEINS IN MICE , 1971, Advances in immunology.
[10] S. McKnight,et al. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. , 1988, Science.
[11] A. Plückthun,et al. Expression of functional antibody Fv and Fab fragments in Escherichia coli. , 1989, Methods in enzymology.
[12] A. Blondel,et al. Engineering the quaternary structure of an exported protein with a leucine zipper. , 1991, Protein engineering.
[13] K. D. Hardman,et al. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. , 1990, Journal of the National Cancer Institute.
[14] S. Fling,et al. Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea. , 1986, Analytical biochemistry.
[15] D M Crothers,et al. The influence of polyvalency on the binding properties of antibodies. , 1972, Immunochemistry.
[16] R. Glockshuber,et al. Crystallization and preliminary X-ray studies of the VL domain of the antibody McPC603 produced in Escherichia coli. , 1990, Journal of molecular biology.
[17] E. Harlow,et al. Antibodies: A Laboratory Manual , 1988 .
[18] S. Morrison,et al. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. , 1988, The EMBO journal.
[19] R. R. Robinson,et al. Escherichia coli secretion of an active chimeric antibody fragment. , 1988, Science.
[20] Y. Satow,et al. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. , 1985, Journal of molecular biology.
[21] P. S. Kim,et al. Evidence that the leucine zipper is a coiled coil. , 1989, Science.
[22] A. Plückthun. Antibody Engineering: Advances From the Use of Escherichia coli Expression Systems , 1991, Bio/Technology.
[23] T. N. Bhat,et al. Small rearrangements in structures of Fv and Fab fragments of antibody D 1.3 on antigen binding , 1990, Nature.
[24] A. Plückthun. Antibodies from Escherichia coli , 1990, Nature.
[25] S. Challacombe,et al. ELISA and other solid phase immunoassys : theoretical and practical aspects , 1988 .
[26] R. Bird,et al. Single chain antibody variable regions. , 1991, Trends in biotechnology.
[27] R. Glockshuber,et al. Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603. , 1991, Biochemistry.
[28] Thomas A. Kunkel,et al. Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[29] J Deisenhofer,et al. Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. , 1980, Journal of molecular biology.
[30] D Eisenberg,et al. The design, synthesis, and crystallization of an alpha‐helical peptide , 1986, Proteins.
[31] R. Glockshuber,et al. Structural features of the McPC603 Fab fragment not defined in the X‐ray structure , 1990, FEBS letters.
[32] L. Regan,et al. Characterization of a helical protein designed from first principles. , 1988, Science.
[33] J. Richardson,et al. The anatomy and taxonomy of protein structure. , 1981, Advances in protein chemistry.
[34] R. Glockshuber,et al. A comparison of strategies to stabilize immunoglobulin Fv-fragments. , 1990, Biochemistry.
[35] B. Chesebro,et al. Affinity labeling of a phosphorylcholine binding mouse myeloma protein. , 1972, Biochemistry.
[36] L. Riechmann,et al. Use of 2D NMR, protein engineering, and molecular modeling to study the hapten-binding site of an antibody Fv fragment against 2-phenyloxazolone. , 1991, Biochemistry.
[37] A. Plückthun,et al. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.
[38] W. DeGrado,et al. Design of a 4-helix bundle protein: synthesis of peptides which self-associate into a helical protein , 1987 .
[39] S. Morrison,et al. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[40] James C. Hu,et al. Sequence requirements for coiled-coils: analysis with lambda repressor-GCN4 leucine zipper fusions. , 1990, Science.
[41] D Eisenberg,et al. Crystal structure of alpha 1: implications for protein design. , 1990, Science.